Skip to main content
. 2018 Nov 22;19(12):3702. doi: 10.3390/ijms19123702

Figure 1.

Figure 1

Imaging biomarkers of neurodegeneration. Coronal structural MRI section (panel A) and 18F-fluorodeoxyglucose (FDG) PET (panel B) from a patient with Alzheimer’s disease (AD).